Sign in
4

Changes in Ownership

BlossomHill Therapeutics, Inc. Filed Acc 0001772259-26-000005

President and CEO acquired 1,838,896 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Cui Jingrong Jean President and CEO 2026-08-10 Conversion +1,600,682 1,600,682 I
Cui Jingrong Jean President and CEO 2026-08-10 Conversion +113,435 1,714,117 I
Cui Jingrong Jean President and CEO 2026-08-10 Conversion +124,779 124,779 I
Derivatives
Cui Jingrong Jean President and CEO 2026-08-06 Grant or award · Employee Stock Option (Right to Buy) +676,205 676,205 D
Cui Jingrong Jean President and CEO 2026-08-10 Conversion · Series Angel Preferred Stock −1,600,682 0 I
Cui Jingrong Jean President and CEO 2026-08-10 Conversion · Series B Preferred Stock −113,435 0 I
Cui Jingrong Jean President and CEO 2026-08-10 Conversion · Series B Preferred Stock −124,779 0 I
Loading xslF345X06/form4-08102026_100800.xml…